Page 20 - Bharat Biotech

Bharat Biotech: A journey that started with a scientist's return to India

First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India

Serum, Bharat Biotech vaccines get restricted use approval from DCGI

While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India

Controversy around Bharat Biotech's Covaxin approval without efficacy data

Bharat Biotech's Covaxin is based on a whole inactivated virus platform, an old technology which is used to make vaccines given to infants

ICMR says clinical trial data show Bharat Biotech's Covaxin is 'safe'

Indian Council of Medical Research (ICMR) on Sunday said data generated through pre-clinical studies and various phases of clinical trial shows Covaxin is 'safe'

All risks paid off, India proud: SII, Bharat Biotech on Covid vaccine nod

With the government approving two Covid-19 vaccines for emergency use, Serum Institute said it is ready to roll out Covishield vaccine in India in the coming weeks

Congress not proud of anything Indian: Nadda over vaccine approval concerns

"Congress and the Opposition is not proud of anything Indian. They should introspect about how their lies on the Covid-19 vaccine will be used by vested interest groups for their own agendas," he said

Congress leaders divided over DCGI approval to Bharat Biotech's Covaxin

Some Congress leaders raised serious concern over the grant of approval to Bharat Biotech's Covid-19 vaccine for restricted use, saying it is "premature" and can prove dangerous

Kejriwal lauds scientists and doctors after DCGI nod to two Covid vaccines

Delhi Chief Minister Arvind Kejriwal said that approval for the emergency use of two "made in India" vaccines will give a positive direction to the country's fight against coronavirus

WHO hails India's emergency use authorisation approval to Covid vaccines

World Health Organisation (WHO) has welcomed India's decision giving emergency use authorisation to Covid-19 vaccines, informed Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia

A decisive turning point: PM Modi on coronavirus vaccine approval

Prime Minister Modi lauded scientists of the country after DCGI gave approval to Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use

Our goal now is to provide it globally: Bharat Biotech on Covaxin approval

Bharat Biotech on Sunday said the approval for emergency use of its Covid-19 vaccine-- Covaxin-- is a giant leap for innovation and novel product development in India

Approval for vaccines accelerates India's journey to be Covid-free: Modi

Modi said it will make every Indian proud that both the vaccines are made in India

India approves two coronavirus vaccines for restrictive, emergency use

Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use

'Covishield' vaccine ready to roll out in coming weeks: Adar Poonawalla

Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca COVID-19 vaccine 'Covishield' is ready to roll out in the coming weeks. Poonawalla's remarks came soon after after India's drugs regulator approved Covishield for restricted emergency use. "Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks," Poonawalla tweeted. "Thank you Hon. Sri @narendramodi Ji, Hon. Sri @drharshvardhan Ji, @MoHFW_INDIA @ICMRDELHI @DBTIndia #DCGI_India @UniofOxford @AstraZeneca @gavi @GaviSeth @gatesfoundation and @BillGates for your support," he added.

Bharat Biotech recruits 23,000 volunteers for Phase-3 Covaxin trials so far

The Phase III human clinical trials of Covaxin, which began in mid-November last year, require 26,000 volunteers across India

Expert panel clears Bharat Biotech's vaccine for restricted emergency use

This comes a day after giving similar direction for the Oxford Covid-19 vaccine

Serum Institute gets SEC thumbs up; Bharat Biotech proposal being discussed

US giant Pfizer did not come to present its case on Friday before the Subject Expert Committee

Drug controller hints vaccine approval will make it a 'happy new year'

V G Somani's statement comes even as subject expert committee is set to meet on Jan 1 to consider three emergency-use authorisation applications

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Sources close to the development said the expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine

CDSCO panel to reconvene on Jan 1 to consider vaccine's emergency use

An expert panel in the Central Drugs Standard Control Organisation that met on Wednesday to consider emergency use authorisation applications will reconvene on Jan 1 to deliberate on the matter.